Well, I think our position on this is clear: It ought to have been evaluated as a remedy under our framework.
The concerns we had with the remedy proposed included that there weren't sufficient assets being divested with the Freedom business to allow them to compete on a similar footing to what Shaw was competing on. They didn't have the assets and that was key.
There was another concern about the contractual arrangements that were undertaken with Rogers. We generally want to see that a new competitor is going to have the assets and is going to be independent from a competitor with respect to all fundamentals of supply.